Phyllis Whiteley
Venture Partner @ Playground Global
San Mateo, United States
Phyllis Whiteley is a seed investor at Playground Global in San Mateo focused on Health Care and Therapeutics. Phyllis Whiteley, PhD., is a Venture Partner with Wildcat Venture Partners where she provides hands-on leadership in building, investing, and creating companies in the digital health space. Phyllis’ career is founded on her passion for personalized medicine, global healthcare, and transformative life science innovations. She has founded and builtmultiple companies in the United States and abroad.Her executive expertise includes strategic planning, financing, partnerships, restructuring, building executive teams and M&A. Prior to joining Wildcat Venture Partners and Mohr Davidow Ventures, Phyllis was an Officer and Senior Vice President, Business Development, Licensing, and Alliance Management at Perlegen Sciences, Inc. Before joining Perlegen, she served as Vice President, Strategic Portfolio Management for Roche. Over her ten-year career with Roche she held various positions in Business Development based in Basel, Switzerland coupled with R&D leadership positions in the US. Phyllis also held a Senior Research Immunology role with Merck.Phyllis is dedicated to helping social entrepreneurs address the problems of poverty, empower women, and build resilience to climate change. She sits on the boards of the Personalized Medicine Coalition, UCSF Leadership Council for Global Health, University of Michigan School of Nursing Board for Science and Innovation, and chairs the advisory board for the University of Texas Horizon Fund. Phyllis also serves on the board of Alydia Health, a medical device company treating Post Partum Hemorrhage around the world, and is a Global Social Benefits Mentor at Santa Clara University.Phyllis holds a BA in Chemistry and Ph.D. in Pharmacology from Washington University, St. Louis, Missouri.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Phyllis Whiteley invests in
Stages Phyllis Whiteley invests in
Countries Phyllis Whiteley invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 1 (100%)
- Therapeutics 1 (100%)
- Biotechnology 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Lassogen is a biotechnology company exploring lasso peptides as a way to develop new medicines.Lassogen was founded in 2019 to unlock the full potential of lasso peptides as a new therapeutic modality for diagnosing and treating some of our most intractable health challenges. The company is the result of a convergence of technological advancesthat have opened the door to a vast, new, untapped source of novel medicines. | $4.5M / Seed / Oct 13, 2020 |
Co-Investors
About Playground Global
Playground Global is an early-stage venture capital firm backing technical and scientific founders with deep engineering expertise, a collaborative environment, and a first-hand understanding of the intricacies of deep tech. Established in 2015 and headquartered in Palo Alto, CA, Playground’s mission is to transform ambitious ideas into impactful businesses that benefit humanity and the planet. We invest in areas that span across next gen compute automation, energy transition and engineered biology. Playground has been an early – and frequently first investor – in companies that include PsiQuantum, Relativity Space, Ultima Genomics, MosaicML (acq. by Databricks), d-Matrix, and Strand Therapeutics.
Playground Global Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Jeffrey Freburg
VP of Operations and Real Estate and Head of Employee Experience
|
|||
Matthew Hershenson
Founding Partner, Co-Founder, and General Partner
|
|||
|
Phyllis Whiteley
Venture Partner
|
|||
Bruce Leak
Co-Founder, Founding Partner & General Partner
|
|||
Greg Wilson
CFO
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Phyllis Whiteley invest in?
Phyllis Whiteley invests primarily in Health Care, Therapeutics and Biotechnology startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Phyllis Whiteley?
Public channels for Phyllis Whiteley include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Phyllis Whiteley last invest?
The most recent investment recorded for Phyllis Whiteley closed in Oct 2020. Shizune tracks 1 investment in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
